Artwork for podcast Gastrointestinal Cancer Update
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
Episode 321st March 2024 • Gastrointestinal Cancer Update • Dr. Neil Love
00:00:00 01:01:41

Share Episode

Shownotes

Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers.

Follow

Links

Chapters

Video

More from YouTube